The lentiviral construct pHR-cPPT-SIEW-RUNX1/ETO (p-SIEW-RR) was generated by inserting the RUNX1/ETO coding region into the BamHI site in the pHR-cPPT-SIEW lentiviral transfer vector (kindly provided by Michela Scherr, Hannover) thus linking RUNX1/ETO with enhanced green fluorescent protein (EGFP) expression via an internal ribosomal entry site (Supplementary Figure 1A) . Lentivirus was produced as previously described (Bomken et al, 2013) . Briefly, HEK293T cells were seeded in tissue culture plates and combined with calcium phosphate precipitates containing the lentiviral packaging plasmids pMD2.G, pCMVR8.91 and p-SIEW-RR. Lentivirus was collected 72 hours after
initial transduction by ultracentrifugation. Target cells were transduced by spinfection at 1500g in 6-well tissue culture dishes for 2 hours at 32°C with 4μg/ml polybrene (Sigma Aldrich, Poole, UK). Cells were initially assessed for successful transduction by flow cytometry for EGFP and later real-time qRT-PCR and western blotting.
Cell cultures
TK6 (Kindly provided by Prof. W. Thilly, MIT, MA, USA) and Kasumi-1 were cultured in RPMI 1640 medium, supplemented with 10% FBS, 100 units/ml penicillin and 0.1mg/ml streptomycin. HEK293T lentiviral producer cells were cultured in DMEM (HEPES modification), supplemented with 10% FBS, 8nM L-glutamine and 1mM sodium pyruvate.
SKNO-1 were cultured in RPMI 1640 medium supplemented with 20% FBS, 100 units/ml penicillin, 0.1mg/ml streptomycin and 10ng/ml granulocyte-macrophage colony stimulating factor. Kasumi-1, SKNO-1 and HEK293T cell lines were acquired from Leibniz Institut, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ), Braunschweig, Germany. All cell culture media and supplements were acquired from Sigma Aldrich, unless otherwise stated.
Selection of successfully transduced cells
Three days after transduction with lentivirus, TK6 were transferred to 96-well plates at a mean density of 2 cells per well in 200μl of culture media and incubated for 10-14 days to isolate individual clonal populations. TK6 clones were assessed for successful lentiviral transduction initially by flow cytometry for EGFP and subsequently for RUNX1/ETO transcript and protein by real-time quantitative PCR and Western analysis, respectively.
Assessment of cell proliferation
Cells were seeded at 2 x 10 4 cells/ml and growth was assessed every 24 hours by cell counting using trypan blue exclusion with an improved Neubauer haemocytometer (VWR International Limited, Leicestershire, UK). A minimum of 2 separate preparations were counted for each cell sample and the average was taken to calculate cell concentration.
Real-time quantitative PCR
RNA was isolated using the RNeasy Mini Kit according to manufacturer's instructions 
Western analysis
Whole cell protein extracts were generated from 10 6 cells using sodium dodecyl sulphate (SDS) extraction. Briefly, cell pellets were prepared by centrifugation at 300g before washing twice in PBS to remove protein contamination from media. Pellets were then resuspended in SDS sample buffer (62.5mM Tris-HCl pH 6.8, 2% (w/v) SDS, 20% (v/v) glycerol), followed by boiling samples at 100°C for 5 minutes. Samples were then centrifuged at 14,000g to pellet cell debris and protein-containing supernatants were stored at -80°C. 
Irradiation of cells
Cell suspensions were irradiated in a 25cm 3 tissue culture flasks using a D3300 X-Ray system (Gulmay Medical Ltd, Surrey, UK) at a dose rate of 2.4Gy/min.
Cytotoxicity assays
Cells in logarithmic phase were irradiated or treated with drug (or vehicle control) and growth inhibition was calculated using trypan blue exclusion with an improved Neubauer haemocytometer (VWR International Limited) to count cells at multiple time points after exposure.
Electroporation of cell lines with siRNA
10 7 cells were pelleted by centrifugation at 300g for 5 minutes and resuspended in fresh media. The cell suspension was transferred to an electroporation cuvette with 4mm electrode gap (PEQLAB, Southampton, UK). The required amount of 20μM siRNA stock solution to give a final concentration of between 10-500nM was added to the cuvette. The cuvette was electroporated at 330V (Kasumi-1) or 350V (SKNO-1) for 10ms using an EPI 2500 electroporator (Fischer, Heidelberg, Germany).
Determination of mutation frequency (Mf) at the thymidine kinase (TK) locus
Prior to experimental use, cell populations were purged of pre-existing TK mutants by 48-hour culture in CHAT medium (standard growth medium supplemented with 10μM 2-deoxycycline, 17.5μM thymidine, 200μM hypoxanthine and 0.2μM aminopterin; all chemicals were from Sigma Aldrich) followed by 72 hours in THC medium (as CHAT, but without aminopterin). For assessment of drug-induced Mf, exponentially growing cell populations were dosed by supplementing drug (or vehicle control) into standard growth medium.
Following 4 hours exposure to doxorubicin at a final concentration of 100nM in 10ml cell culture medium in 25cm 3 flasks, cells were washed in PBS and Mf was determined according to the method of Liber and Thilly (1982) . The frequency of mutations attributable to doxorubicin or radiation (treatment-induced Mf) was calculated by subtracting the Mf in mock-treated cells from the Mf in doxorubicin or radiation-treated cells.
Determination of surface CD55 and CD59 status by flow cytometry
Mutation using loss of CD55 and CD59 as a surrogate for loss of PIGA was performed as previously described (Chen et al, 2001; Krüger et al, 2014) . Briefly, expression of two GPIanchored proteins (CD55 and CD59) was determined on TK6 cells using PE conjugated antibodies. Cells were also assessed for expression of CD19 B-cell marker and exclusion of propidium iodide (PI) as a cell viability stain. CD55-PE (clone IA10), CD59-PE (clone p282 (H19)) and CD19-APC (clone SJ25C1) conjugated antibodies were all purchased from BD Biosciences (Oxford, UK). Base substitutions and small insertions/deletions in the PIGA gene are the predominant mechanism leading to loss of surface CD55/CD59 expression in vivo (diagnostic for paroxysmal nocturnal hemoglobinuria (Shen et al, 2014) ) and cell line studies in vitro (Chen et al, 2001 ). However, we cannot exclude the possibility that other 
ChIPseq, RNAseq and DNase 1 hypersensitivity site mapping
ChIPseq, RNAseq and Dnase1 hypersensitivity mapping were performed as previously described (Ptasinska et al, 2014) .
